Pilot study of topical delivery of methotrexate by electroporation

British Journal of Dermatology

Volumn 152, Issue 3, 2005, Pages 524-530

  Wong, Tak Wah ^a   Zhao, Y L ^b   Sen, A ^b   Hui, S W ^b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Lipid; Methotrexote; Psoriasis; Skin; Transport

Indexed keywords

METHOTREXATE; RADIOISOTOPE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DIFFUSION; DRUG TRANSPORT; ELECTRODE; ELECTROPORATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IONTOPHORESIS; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; PUNCH BIOPSY; STRATUM CORNEUM; SWINE;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; DERMATOLOGIC AGENTS; DIFFUSION CHAMBERS, CULTURE; DRUG DELIVERY SYSTEMS; ELECTROPORATION; HYPOTHERMIA, INDUCED; LIPOSOMES; METHOTREXATE; PHOSPHOLIPIDS; PILOT PROJECTS; SKIN ABSORPTION; SWINE;

EID: 17444374247     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06455.x     Document Type: Article

References (27)

1. Roenigk HH Jr, Auerbach R, Maibach H et al. Methotrexate in psoriasis: consensus conference. J Am Acad Dermatol 1998; 38:478-85.
2. Stewart WD, Wallace SM, Runikis JO. Absorption and local action of methotrexate in human and mouse skin. Arch Dermatol 1972; 106:357-61.
3. McCullough JL, Synder DS, Weinstein GD et al. Factors affecting human percutaneous penetration of methotrexate and its analogues in vitro. J Invest Dermatol 1976; 66:103-7.
4. Chatterjee DJ, Li WY, Koda RT. Effect of vehicles and penetration enhancers on the in vitro and in vivo percutaneous absorption of methotrexate and edatrexate through hairless mouse skin. Pharm Res 1997; 14:1058-65.
5. Weinstein GD, McCullough JL, Olsen E. Topical methotrexate therapy for psoriasis. Arch Dermatol 1989; 125:227-30.
6. Sutton L, Swinehart JM, Cato A, Kaplan AS. A clinical study to determine the efficacy and safety of 1% methotrexate/Azone (MAZ) gel applied topically once daily in patients with psoriasis vulgaris. Int J Dermatol 2001; 40:464-7.
7. Syed TA, Hadi SM, Qureshi ZA et al. Management of psoriasis vulgaris with methotrexate 0.25% in a hydrophilic gel: a placebo-controlled, double-blind study. J Cutan Med Surg 2001; 5:299-302.
8. Alvarez-Figueroa MJ, Blanco-Mendez J. Transdermal delivery of methotrexate: iontophoretic delivery from hydrogels and passive delivery from microemulsions. Int J Pharm 2001; 215:57-65.
9. Alvarez-Figueroa MJ, Delgado-Charro MB, Blanco-Mendez J. Passive and iontophoretic transdermal penetration of methotrexate. Int J Pharm 2001; 212:101-7.
10. Hui SW, Stenger DA. Effects of intercellular forces in electrofusion. In: Guide to Electroporation and Electrofusion (Chang DC, Chassy BM, Saunders JA, Sowers AE, eds). New York: Academic Press, 1992: 167-78.
11. Johnson PG, Hui SW, Oseroff AR. Electrically enhanced percutaneous delivery of delta-aminolevulinic acid using electric pulses and a DC potential. Photochem Photobiol 2002; 75:534-40.
12. Johnson PG, Gallo SA, Oseroff AR, Hui SW. Transdermal transport of methylene blue through full-thickness porcine skin by electroporation- electrophoresis. J Invest Dermatol 1998; 111:457-63.
13. Sen A, Zhao YL, Zhang L, Hui SW. Enhanced transdermal transport by electroporation using anionic lipids. J Control Release 2002; 82:399-405.
14. Sen A, Zhao YL, Hui SW. Saturated anionic phospholipids enhance transdermal transport by electroporation. Biophys J 2002; 83:2064-73.
15. Sen A, Daly ME, Hui SW. Transdermal insulin delivery using lipid-enhanced electroporation. Biochim Biophys Acta 2002; 1564:5-8.
16. Gothelf A, Mir LM, Gehl J. Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation. Cancer Treat Rev 2003; 29:371-87.
17. Mir LM, Glass LF, Sersa G et al. Effective treatment of cutaneous and subcutaneous malignant tumors by electrochemotherapy. Br J Cancer 1998; 77:2336-42.
18. Gallo SA, Sen A, Hensen ML, Hui SW. Temperature-dependent electrical and ultrastructural characterization of porcine skin upon electroporation. Biophys J 2002; 82:109-19.
19. Murthy SN, Sen A, Zhac YL, Hui SW. Temperature influences the postelectroporation permeability state of skin. J Pharm Sci 2004; 93:908-15.
20. Prausnitz M, Bose V, Langer R, Weaver JC. Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery. Proc Natl Acad Sci USA 1993; 90:10504-8.
21. Wolff K, Kibbi AG, Mihn MC Jr. Basic pathologic reactions of the skin. In: Fitzpatrick's Dermatology in General Medicine (Freedberg IM, Eisen AZ, Wolff K et al. eds), 5th edn, Vol. 1, New York: McGraw-Hill, 1999: 41-55.
22. Pliquett UF, Zewert TE, Chen T et al. Imaging of fluorescent molecule and small ion transport through human stratum corneum during high voltage pulsing: localized transport regions are involved. Biophys Chem 1996; 58:185-204.
23. Harth Y, Hirshowitz B, Kaplan B. Modified topical photodynamic therapy of superficial skin tumors, utilizing aminolevulinic acid, penetration enhancers, red light, and hyperthermia. Dermatol Surg 1998; 24:723-6.
24. Ilic L, Gowrishankar TR, Vaughan TE et al. Spatially constrained skin electroporation with sodium thiosulfate and urea creates transdermal microconduits. J Control Release 1999; 61:185-202.
25. Hoffmann GA. Instrumentation and electrodes for in vivo electroporation. In: Methods in Molecular Medicine (Jaroszesk MJ, Heller R, Gilbert R, eds), Vol. 37, New York: Humana Press Inc., 2000: 17-61.
26. Pratt WB, Ruddon RW, Ensminger WD, Maybaum J. Antimetabolites. In: The Anticancer Drugs, 2nd edn. New York: Oxford University Press Inc., 1994: 69-107.
27. Bender T, Bariska J, Rojkovich B, Balint G. Elofenamate levels in human serum and synovial fluid following iontophoresis. Arzneimittelforschung 2001; 51:489-92.